ARCHIVES

Amgen, Genentech Drug Giveaway Programs Likely to Meet Resistance From Doctors, Potential Problems at CMS.

This article is from The Cancer Letter archive.

Vol. 32 No. 36 | October 13, 2006

Download PDF Visit The Full Archive

Related Articles

NCA Uneasy Over Possible NIH Takeover Of FCRC, But It Won’t Happen

June 13, 1980

Guest Editorial: FDA Must Address Economic Incentives to Resolve Drug Shortages Permanently

February 24, 2012

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010

Agreement Nears On New Guidelines For Center Grants

November 14, 1980

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998

Breast Cancer Funding: Shalala Approves Agreement Over Disputed $14 Million

August 8, 1997